Please ensure Javascript is enabled for purposes of website accessibility
Accessibility Menu
BioNTech Se Stock Quote

BioNTech Se (NASDAQ: BNTX)

$88.49
(0.5%)
$0.48
Price as of April 23, 2024, 4:00 p.m. ET

BioNTech Se Return vs. S&P

1 Year 5 Year 5 Year Annualized Since IPO
BNTX -25.59% +524%
S&P +21.22% +71.17% +11.35% +71%

BioNTech Se Company Info

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. The company was founded by Christopher Huber, Oezlem Tuereci, and Ugur Sahin on June 2, 2008 and is headquartered in Mainz, Germany.

News & Analysis

The Fool has written over 300 articles on BioNTech Se.

Valuation

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.